Myriam Perla Mazloum

Early versus late starting of direct oral anticoagulants after breakthrough ischemic stroke: A target trial analysis from the ASPERA-R study

Lucio D’Anna, Matteo Foschi, Francesca Gabriele, Raffaele Ornello et autres

BACKGROUND AND PURPOSE: Randomized trials support early initiation of direct oral anticoagulants (DOACs) after atrial fibrillation (AF)-related ischemic stroke, but patients with breakthrough ischemic stroke occurring despite ongoing anticoagulation have been largely under-represented. We evaluated the effectiveness and safety of early versus …

gb, it, fr, es, pt, Égypte, hr, de, us, sa, ch (code pays fourni par la source)

Impact of cancer on outcomes following breakthrough ischaemic stroke on oral anticoagulants for atrial fibrillation: insights from the ASPERA-R study.

Matteo Foschi, Federico De Santis, Francesca Gabriele, Lucio D'Anna et autres

BACKGROUND: Breakthrough ischaemic stroke during oral anticoagulation (OAC) for atrial fibrillation (AF) represents a major therapeutic challenge, especially in patients with cancer, who face competing risks of thrombosis and bleeding. This study investigated the impact of cancer on 90-day outcomes after ischaemic …

it, gb, fr, es, pt, jp, Égypte, hr, de, sa, us, ch (code pays fourni par la source)

Systematic review and meta-analysis on mortality and functional outcome in patients with large cerebellar infarctions treated with neurosurgery

Myriam Perla Mazloum, Hilde Hénon, Alberto Coccia, Julien Labreuche et autres

Background: Management of large cerebellar infarctions with potential malignant evolution is highly heterogeneous across physicians, and recommendations rely on low-evidence studies. Aim: We aimed to perform a systematic review and meta-analysis on patients with large cerebellar infarction undergoing neurosurgery, to study mortality …

fr (code pays fourni par la source)

Early treatment with rituximab in Susac syndrome

Myriam Perla Mazloum, Mikaël Cohen, Saskia Bresch, Lydiane Mondot et autres

fr (code pays fourni par la source)

Traitement précoce du syndrome de Susac par rituximab

Myriam Perla Mazloum, Mikaël Cohen, Saskia Bresch, Lydiane Mondot et autres

fr (code pays fourni par la source)